This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.
tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.
tim.hodson Fri, 03/28/2025 - 15:23 Mar. This innovative technology maximizes operational efficiency, enhances staff expertise, and delivers better patient outcomes, making it a wise long-term investment. a huge win: CMS significantly increases Medicare payments for cardiac CT. 2012) 380:2095128. 10.1016/S0140-6736(12)61728-0.
Stroke, Volume 56, Issue Suppl_1 , Page AWP140-AWP140, February 1, 2025. Clinical data extracted from an EMR-driven registry were linked to PAC utilization information retrieved from a CMS Qualified Entity with 80% data for the Texas state population (including 100% of Medicare Fee-for-Service). female; 63.6% 0.76) (Figure 3).
Stroke, Volume 56, Issue Suppl_1 , Page AWP217-AWP217, February 1, 2025. The Alzheimers Associations expert guidance is to avoid co-prescribing; however, CMS and FDA do not restrict or warn against it. Monthly model outcomes included ICH, ischemic stroke, cognitive impairment, quality-adjusted life months (QALMs), and survival.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP44-AWMP44, February 1, 2025. Conclusion:Cluster analyses can elucidate high-risk patient profiles and guide in identifying intervenable targets and prioritizing provision of appropriate care, including rehabilitation, to optimize long-term patient outcomes. vs. 28.5%) (Fig.
Stroke, Volume 56, Issue Suppl_1 , Page ATP328-ATP328, February 1, 2025. We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Objective:The role of statins in the management of intracerebral hemorrhage (ICH) remains controversial.
Stroke, Volume 56, Issue Suppl_1 , Page AWP311-AWP311, February 1, 2025. Introduction:Cardiomyopathy (CM) can occur in patients hospitalized with acute ischemic stroke (AIS). Demographic characteristics and clinical outcome rates were computed among patients with each CM subtype.
tim.hodson Mon, 01/27/2025 - 09:47 Jan. tim.hodson Mon, 01/27/2025 - 09:47 Jan. This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the SymplicitySpyral renal denervation (RDN) system, used in the Symplicity blood pressure procedure. 5 Bhatt, D.
tim.hodson Mon, 01/13/2025 - 16:47 Jan. 13, 2025 R3 Vascular Inc., Owens, president and chief executive officer of R3 Vascular said, We are very pleased to have received IRB and CMS Category B approval so quickly. Secemsky, M.D., TheNational Institutes of Healthestimates PAD affects 8-12 million people in the U.S.
cms) with moderately reduced systolic function. But it does show a strong association of better outcome with lidocaine vs. amiodarone. Our objective was to use 'target trial emulation' methodology to compare the outcomes of patients who received amiodarone or lidocaine during resuscitation. Smida T et al.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content